Infrastructure Capital Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Infrastructure Capital Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-23,000	Closed	-$298K	–	64
2021 Q2	$298K	Buy	+23,000	New	+$293K	0.05%	49
2018 Q2	–	Sell	-22,003	Closed	-$114K	–	120
2018 Q1	$114K	Buy	22,003 +2,700	+14%	+$14.4K	0.01%	111
2017 Q4	$87K	Buy	+19,303	New	+$107K	0.01%	118
2017 Q3	–	Sell	-16,628	Closed	-$102K	–	110
2017 Q2	$102K	Buy	+16,628	New	+$112K	0.02%	99

Other funds holding AUPH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KPWS

Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Infrastructure Capital Advisors's AUPH Position: Q3 2021 in Review

Infrastructure Capital Advisors sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2021, closing a stake of 23,000 shares — an estimated $298K sold.

Infrastructure Capital Advisors first reported a position in AUPH in Q2 2017 and held it in 4 quarters. The position peaked at $298K in Q2 2021. 166 funds tracked by Wall St. Rank hold AUPH as of Q3 2021.

Infrastructure Capital Advisors reported no remaining Aurinia Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Infrastructure Capital Advisors sold 23,000 Aurinia Pharmaceuticals shares in Q3 2021, an estimated $298K.
Infrastructure Capital Advisors first reported a position in Aurinia Pharmaceuticals in Q2 2017 and held it in 4 quarters.
Infrastructure Capital Advisors's Aurinia Pharmaceuticals position peaked at $298K in Q2 2021.
166 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2021.

Based on Infrastructure Capital Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.